Progressive Pulmonary Artery Band Restriction Is Associated with Restrictive Right Ventricular Physiology After Staged Repair of Complete Atrioventricular Septal Defect
Children · 09.11.2026 · 13 (11) · 1551
DOI: 10.3390/children13111551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Children, online erschienen am 09.11.2026. Verfasst von İlker Mercan und 9 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Pulmonary artery banding (PAB) is used in selected high-risk infants with complete atrioventricular septal defect (AVSD). We examined whether progressive functional band restriction was associated with postoperative restrictive right ventricular (RV) physiology after staged repair.
Methods
This retrospective single-centre cohort included 53 patients who underwent definitive biventricular repair between October 2022 and November 2025 after previous PAB. Postoperative restrictive RV physiology was operationally defined by pulmonary arterial end-diastolic forward flow (EDFF) explicitly documented as present or absent in contemporaneous written postoperative echocardiography reports within 6 h of intensive care admission. Early post-banding and final pre-repair Doppler gradients were compared within patients. Logistic regression assessed associations with EDFF. The primary clinical outcome was a composite major adverse event (MAE), comprising 30-day or in-hospital mortality, postoperative extracorporeal membrane oxygenation, or unplanned cardiac reoperation.
Results
EDFF-defined restrictive RV physiology was identified in 21 patients (39.6%) on the initial postoperative assessment. Pre-repair PAB gradient was higher in EDFF-positive than EDFF-negative patients (93 vs. 72 mmHg; p < 0.001). Median patient-level gradient increase was 45 vs. 29.5 mmHg (p < 0.001). EDFF-positive patients had higher rates of low cardiac output syndrome (71.4% vs. 21.9%) and extracorporeal membrane oxygenation (33.3% vs. 3.1%). MAE occurred in 33.3% versus 12.5% of patients, respectively, without a statistically significant between-group difference (p = 0.090). In the primary adjusted model, pre-repair gradient was associated with EDFF (adjusted odds ratio per 10 mmHg, 5.14; 95% confidence interval, 1.82–14.48; p = 0.002). The association for patient-level gradient increase persisted after adjustment for interstage duration and weight gain (adjusted odds ratio per 10 mmHg, 3.51; 95% confidence interval, 1.65–7.50; p = 0.001).
Conclusions
Greater functional PAB restriction and longitudinal gradient increase were associated with early postoperative EDFF-defined restrictive RV physiology and greater early postoperative morbidity. Findings are exploratory and do not establish causality or a validated intervention threshold.
Zitieren
APA
Mercan, İ., Özdaş, M. E., Aksoy, Ö. N., Özdemir, İ. E., Bilgili, H. F., Doğan, Ö., Korkmaz, Ö., Kaya, Ö., Örün, U. A., & Taşar, M. (2026). Progressive Pulmonary Artery Band Restriction Is Associated with Restrictive Right Ventricular Physiology After Staged Repair of Complete Atrioventricular Septal Defect. Children, 13(11), 1551. https://doi.org/10.3390/children13111551
Vancouver
Mercan İ, Özdaş ME, Aksoy ÖN, Özdemir İE, Bilgili HF, Doğan Ö, et al. Progressive Pulmonary Artery Band Restriction Is Associated with Restrictive Right Ventricular Physiology After Staged Repair of Complete Atrioventricular Septal Defect. Children. 2026;13(11):1551. doi:10.3390/children13111551
BibTeX
@article{Mercan2026,
author = {Mercan, İlker and Özdaş, Muharrem Emre and Aksoy, Ömer Nuri and Özdemir, İbrahim Enes and Bilgili, Hasan Furkan and Doğan, Özge and Korkmaz, Özge and Kaya, Özkan and Örün, Utku Arman and Taşar, Mehmet},
title = {Progressive Pulmonary Artery Band Restriction Is Associated with Restrictive Right Ventricular Physiology After Staged Repair of Complete Atrioventricular Septal Defect},
journal = {Children},
year = {2026},
volume = {13},
number = {11},
pages = {1551},
doi = {10.3390/children13111551}
}
EUVIMED